1. Signaling Pathways
  2. GPCR/G Protein
    Neuronal Signaling
  3. Orexin Receptor (OX Receptor)
  4. OX2 Receptor Isoform

OX2 Receptor

 

OX2 Receptor Related Products (21):

Cat. No. Product Name Effect Purity
  • HY-16725
    Lemborexant
    Antagonist 99.92%
    Lemborexant (E-2006) is a reversible, competitive and orally active dual antagonist of the orexin OX1 and OX2 receptors with IC50 values of 6.1 nM and 2.6 nM, respectively.
  • HY-10895A
    SB-334867 free base
    Antagonist 99.89%
    SB-334867 free base (SB334867A free base) is an excellent, selective and blood–brain barrier permeable orexin-1 (OX1) receptor antagonist, shows selectivity over OX2 (pKb=7.4), 100-fold over 5-HT2B, 5-HT2C with pKi values of 5.4 and 5.3, respectively.
  • HY-10805
    Almorexant
    Antagonist 99.71%
    Almorexant (ACT 078573) is an orally active, potent and competitive dual orexin receptor antagonist, with Kd values of 1.3 nM (OX1) and 0.17 nM (OX2), respectively.
  • HY-10805A
    Almorexant hydrochloride
    Antagonist 99.98%
    Almorexant (ACT 078573) hydrochloride is an orally active, potent and competitive dual orexin receptor antagonist, with Kd values of 1.3 nM (OX1) and 0.17 nM (OX2), respectively.
  • HY-109012
    Seltorexant
    Antagonist 99.62%
    Seltorexant (JNJ-42847922) is an orally active, high-affinity, and selective orexin-2 receptor (OX2R) antagonist (pKi values of 8.0 and 8.1 for human and rat OX2R).
  • HY-109012A
    Seltorexant hydrochloride
    Antagonist 99.90%
    Seltorexant hydrochloride (JNJ-42847922 hydrochloride) is an orally active, high-affinity, and selective OX2R antagonist (pKi values of 8.0 and 8.1 for human and rat OX2R).
  • HY-10900
    TCS 1102
    Antagonist 99.64%
    TCS 1102 is a potent, dual orexin receptor antagonist, with Ki values of 0.2 nM and 3 nM for OX2 and OX1 receptors, respectively.
  • HY-100452
    TCS-OX2-29
    Antagonist 99.24%
    TCS-OX2-29 is a potent, high affinities and selective orexin-2 receptor (OX2R) antagonist with an IC50 value of 40 nM and a pKI value of 7.5.
  • HY-19914
    MK-1064
    Antagonist 99.48%
    MK-1064 is a selective and orally active OX2R antagonist (Ki: 0.5 nM, IC50: 18 nM).
  • HY-10898
    SB-674042
    Antagonist 99.84%
    SB-674042 is a potent and selective non-peptide orexin OX1 receptor antagonist (Kd=5.03 nM), exhibits 100-fold selectivity for OX1 over OX2 receptors with IC50 values of 3.76 nM and 531 nM, respectively.
  • HY-108682
    EMPA
    Antagonist 99.69%
    EMPA is a high-affinity, reversible and selective orexin OX2 receptor antagonist.
  • HY-136181
    YNT-185 dihydrochloride
    Agonist ≥98.0%
    YNT-185 dihydrochloride is a nonpeptide, selective orexin type-2 receptor (OX2R) agonist, with EC50s of 0.028 and 2.75 μM for OX2R and OX1R, respectively.
  • HY-138695
    Orexin 2 Receptor Agonist 2
    Agonist 98.06%
    Orexin 2 Receptor Agonist 2 is a selective orexin 2 receptor agonist, extracted from patent WO2017135306A1, example 16.
  • HY-101834
    ACT-462206
    Antagonist 99.60%
    ACT-462206 is an orally active and potent dual Orexin 1/Orexin 2 receptor antagonist with IC50s of 60 nM (Orexin 1) and 11 nM (Orexin 2), respectively.
  • HY-108683
    ACT-335827
    Antagonist
    ACT-335827 is a selective, orally active, brain-penetrant orexin type 1 receptor antagonist.
  • HY-P1340A
    [Ala11,D-Leu15]-Orexin B(human) TFA
    Agonist
    [Ala11,D-Leu15]-Orexin B(human) TFA is a potent and selective orexin-2 receptor (OX2) agonist.
  • HY-P1341
    OXA(17-33)
    Agonist 98.63%
    OXA(17-33) is a potent and selective orexin-1 receptor (OX1) agonist.
  • HY-P1341A
    OXA(17-33) TFA
    Agonist
    OXA(17-33) TFA is a potent and selective orexin-1 receptor (OX1) agonist.
  • HY-146517
    Orexin receptor antagonist 4
    Antagonist
    Orexin receptor antagonist 4 is potent and selective orexin 2 receptor (OX2R) antagonist with an IC50 of 4.27 nM.
  • HY-P1340
    [Ala11,D-Leu15]-Orexin B(human)
    Agonist
    [Ala11,D-Leu15]-Orexin B(human) is a potent and selective orexin-2 receptor (OX2) agonist.